BioHarvest Sciences Inc.

Recent News

  • BioHarvest Sciences Inc. Appoints Steven Lehrer to Its Board of Advisors

    Steven Lehrer's 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D.His appointment continues to demonstrate the Company's resolve to leverage its biotech technology platform in life science-based businesses. Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - October 27, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that effective immediately, Steven Lehrer will be serving on its board of advisors. Complementing an already competent list of advisors that...

    2021-10-27 8:35 AM EDT
  • BioHarvest Sciences Inc. Announces Appointment of David Tsur to Board of Directors

    David Tsur's 40 years of Biotech experience further strengthens the Board at a critical phase of the Company's growthHis appointment reinforces the Company's primary focus on becoming a Biotech leader, leveraging the power of its platform technology to disrupt multiple business verticals Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 21, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announced that David Tsur has agreed to serve as a non-executive director of BioHarvest. The appointment...

    2021-10-21 8:55 AM EDT
  • BioHarvest Sciences Inc. Increases Its VINIA 2021 Annual Sales Orders Forecast for Israel by 15%

    Vancouver, Canada, and Rehovot, Israel--(Newsfile Corp. - October 13, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announces an update to its forecast of 2021 annual sales orders for VINIA® in Israel. The Company has increased its 2021 sales orders forecast for Israel to US$ 1.6M - US$ 1.7M from the previous forecast of US$ 1.3M - US$ 1.5M announced in March 2021. The continued adoption of VINIA® in Israel demonstrates the health benefits...

    2021-10-13 8:55 AM EDT
  • BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event October 14, 2021, at 2:00pm E.T.

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 12, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, October 14, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a detailed performance update on the commercialization of the...

    2021-10-12 8:55 AM EDT
  • BioHarvest Sciences Inc Announces the Closing of Its Previously Announced Private Placement and the Amount Raised from Exercise of Warrants

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces the closing of its second and final tranche of the private placement announced on August 4th, 2021. Under this private placement, the Company issued a total of 7,781,375 units ("each a Unit') for proceeds of CAD$ 3,501,619 with net proceeds of CAD$ 3,484,849 after payment of commissions and finders fees of CAD$ 16,770.Under the first tranche the Company issued 6,845,368...

    2021-10-04 8:55 AM EDT
  • Bioharvest Sciences Inc. Announces Closing of the First Tranche of Its Private Placement

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement (the "Private Placement") previously announced on August 4, 2021. Under the First Tranche, the Company has issued 6,845,368 units (each a "Unit") at $0.45 per Unit for gross proceeds of CAD$ 3,080,415.60, net CAD$ 3,066,850.60 after payment of commissions and finder's fees...

    2021-08-30 8:55 AM EDT
  • BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate Its Cannabis Development Program and Production Capacity in Israel

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that its board of directors has approved a private placement (the "Offering") for up to 8,888,889 units at a price of CAD 0.45 (the "Offering Price") per unit for gross proceeds of up to CAD 4,000,000.Each unit will consist of one common share of the Company (a "Share") in the capital of the Company and one-half (1/2) of...

    2021-08-04 8:55 AM EDT
  • BioHarvest Sciences Inc. Shareholder Update - Live Event July 8, 2021, at 2:00pm E.T.

    Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 8, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a performance update on Israel VINIA® Q2 results and the e-commerce launch of VINIA® in the...

    2021-07-02 9:47 AM EDT